E. Markovits

A novel deep learning pipeline for cell typing and phenotypic marker quantification in multiplex imaging

Ido D. Weiss, I. Barshack, Y. Shachaf, 2022, bioRxiv.

Reprogramming lymphocytes for the treatment of melanoma: From biology to therapy.

G. Markel, E. Markovits, Naama Margolis, 2019, Advanced drug delivery reviews.

Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence

I. Barshack, J. Schachter, S. Kaech, 2019, Cell.

TNFSF4 (OX40L) expression and survival in locally advanced and metastatic melanoma

R. Berger, J. Schachter, J. Roszik, 2019, Cancer Immunology, Immunotherapy.

microRNA expression patterns in tumor infiltrating lymphocytes are strongly associated with response to adoptive cell transfer therapy

J. Schachter, G. Markel, R. Ortenberg, 2020, Cancer Immunology, Immunotherapy.

Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy

G. Salles, M. Perales, M. V. D. van den Brink, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical Proteomics of Metastatic Melanoma Reveals Profiles of Organ Specificity and Treatment Resistance

M. Harel, T. Geiger, G. Markel, 2021, Clinical Cancer Research.

Adenosine-deaminase-acting-on-RNA-1 facilitates T-cell migration toward human melanoma cells.

J. Schachter, T. Meirson, G. Markel, 2022, Cancer immunology research.

Multimodal stimulation screens reveal unique and shared genes limiting T cell fitness

D. Peeper, G. Markel, Onno B. Bleijerveld, 2024, Cancer cell.